5 hours Ago
Choice Equity Broking has a buy call on Glenmark Pharmaceuticals with a target price of Rs 1,779. The current market price of Glenmark Pharmaceuticals Ltd. is Rs 1489.
35. Glenmark Pharmaceuticals, incorporated in the year 1977, is a Mid Cap company with a market cap of Rs 42120.82 crore, operating in the Pharmaceuticals sector.
Glenmark Pharmaceuticals' key products/revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the year ending 31-Mar-2023. Financials For the quarter ended 30-09-2024, the company has reported a Consolidated Total Income of Rs 3473.21 crore, up 6.
03 % from last quarter Total Income of Rs 3275.68 crore and up 8.23 % from last year same quarter Total Income of Rs 3209.
08 crore. The company has reported net profit after tax of Rs 354.48 crore in the latest quarter.
Investment Rationale The growth of Glenmark will be driven by revenue expansion through new product launches in Europe and the US, improved EBITDA margins, a double-digit PAT margin, a strong contribution from RYALTRIS and a strong capex cycle. Choice Equity Broking anticipates a CAGR in revenue and EBITDA of 14.8% and 44.
7%, respectively, from FY24-27E. They have introduced FY27E and valued the stock based on Sep-FY27E EPS to arrive at a target price of Rs 1,779 (25x) and recommended a BUY rating on the stock. Stock Trading Derivative Analytics Made Easy By - Vivek Bajaj, Co Founder- Stockedge and Elearnmarkets View Program Stock Trading Stock Markets Made Easy By - elearnmarkets, Financial Education by StockEdge View Program Stock Trading Market 104: Options Trading: Kickstart Your F&O Adventure By - Saketh R, Founder- QuickAlpha, Full Time Options Trader View Program Stock Trading Introduction to Technical Analysis & Candlestick Theory By - Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert View Program Stock Trading Cryptocurrency Made Easy: Cryptocurrency Course By - elearnmarkets, Financial Education by StockEdge View Program Stock Trading Market 101: An Insight into Trendlines and Momentum By - Rohit Srivastava, Founder- Indiacharts.
com View Program Stock Trading ROC Made Easy: Master Course for ROC Stock Indicator By - Souradeep Dey, Equity and Commodity Trader, Trainer View Program Stock Trading Advanced Strategies in Stock Market Mastery By - CA Raj K Agrawal, Chartered Accountant View Program Stock Trading Heikin Ashi Trading Tactics: Master the Art of Trading By - Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert View Program Stock Trading Options Trading Course For Beginners By - Chetan Panchamia, Options Trader View Program Stock Trading A2Z of Stock Trading - Online Stock Trading Course By - elearnmarkets, Financial Education by StockEdge View Program Promoter/FII Holdings Promoters held 46.65 per cent stake in the company as of 30-Sep-2024, while FIIs owned 23.05 per cent, DIIs 13.
21 per cent. (You can now subscribe to our ETMarkets WhatsApp channel ).
